Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 1;22(1):321.
doi: 10.1186/s12879-022-07287-5.

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients

Raksha Rimal  1 , Dhiraj Shrestha  1 , Susil Pyakurel  2 , Rashmi Poudel  1 , Prasha Shrestha  3 , Kul Raj Rai  3 , Gokarna Raj Ghimire  4 , Ganesh Rai  1 , Shiba Kumar Rai  5
Affiliations

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients

Raksha Rimal et al. BMC Infect Dis. .

Abstract

Background: Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide. Control of TB is lingering by the lack of diagnostic tests that are simple, rapid, yet accurate. Thus, smear-negative pulmonary TB often misses the diagnosis. The study evaluated the performance of GeneXpert MTB/RIF assay for the detection of Mycobacterium tuberculosis (MTB).

Methods: The study was carried out from June to December 2016 in Nepal Tuberculosis Center, Bhaktapur, Nepal. A total of 173 sputum samples were collected and processed by microscopy [Auramine-O staining and Ziehl-Neelsen (ZN) staining], followed by GeneXpert MTB/RIF assay and culture in Lowenstein-Jensen (LJ) medium.

Results: Of 173 sputum samples, 162 (93.6%) were smear-negative. Of 162 smear-negative sputum samples, 35 (21.6%) were confirmed to have MTB by culture, and 31 (19.1%) by GeneXpert MTB/RIF assay. Of 31 GeneXpert-positive samples, 25 (80.6%) were susceptible, 4 (12.9%) were resistant, and 2 (6.45%) were intermediate to rifampicin. The sensitivity, specificity, positive predictive value, and negative predictive value of GeneXpert MTB/RIF assay for smear-negative sputum samples were 74.3%, 96.6%, 86.7%, and 92%, respectively. The GeneXpert MTB/RIF has a substantial diagnostic agreement of 90.91% with culture (Cohen's Kappa coefficient = 0.73).

Conclusion: The diagnostic performance of GeneXpert MTB/RIF assay was almost on par with culture, and thus can be relied upon for MTB detection in smear-negative sputum samples.

Keywords: GeneXpert MTB/RIF; MTB; Mycobacterium tuberculosis; Nepal; Smear-negative.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. World Health Organization (WHO): Tuberculosis. https://www.who.int/news-room/fact-sheets/detail/tuberculosis (2020). Accessed 12 Aug 2021.
    1. World Health Organization (WHO): Global Tuberculosis Report 2020. 2020. https://www.who.int/publications/i/item/9789240013131.
    1. World Health Organization (WHO): Tuberculosis diagnostics workshop: product development guidelines. Cleveland, Ohio; 1997. https://www.who.int/tdr/publications/documents/tuberculosis-diagnostics.pdf.
    1. Jorgensen JH, Pfaller MA, Carroll KC, Funke G, Landry ML, Richter SS, Warnock DW. Manual of Clinical Microbiology. 11. Washington: ASM Press; 2015.
    1. William T, Parameswaran U, Lee WK, Yeo TW, Anstey NM, Ralph AP. Pulmonary tuberculosis in outpatients in Sabah, Malaysia: advanced disease but low incidence of HIV co-infection. BMC Infect Dis. 2015;15(1):32. doi: 10.1186/s12879-015-0758-6. - DOI - PMC - PubMed

LinkOut - more resources